Emily Whitehead, the first child to be cured of cancer with Penn-invented CAR-T therapy, is now a freshman at Penn
From American Sign Language to English to nature photography, Emily has a wide range of interests she intends to explore in her studies.
Penn spinout Interius Biotherapeutics raises another $21.5M
Co-founded by Saar Gill, MD, PhD, Interius is developing a new platform for cell-specific gene delivery in patients.
Penn Faculty Discover An Innovative Potential Treatment for Tooth Decay
In search of a more effective treatment, the research team employed a combination of ferumoxytol (Fer) and stannous fluoride (SnF2) to fight tooth decay.
National Academy of Medicine Elects Five Penn Experts
Five Penn experts have been elected to the National Academy of Medicine (NAM), one of the nation’s highest honors in the fields of health and medicine.
Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space
A group of Penn scientists and engineers is moving into 115,000 square feet of new lab space in the 13-story One uCity Square building in West Philadelphia.
Team members of I Corps Team and Penn President’s Prize Winner Sonura are Named Philadelphia Business Journal’s “Inno Under 25”
The group was named as 2023’s Inno Under 25 honorees by the Philadelphia Business Journal.
Katalin Karikó and Drew Weissman Named Co-Recipients of the 2023 Nobel Prize for Medicine
Penn’s Katalin Karikó, PhD, and Drew Weissman, MD, PhD, have been named winners of the 2023 Nobel Prize in Physiology or Medicine.
Mitchell Named “Young Innovator of Cellular and Molecular Bioengineering”
Mike Mitchell, PhD, J. Peter and Geri Skirkanich Assistant Professor of Innovation in Bioengineering (BE), was named a "Young Innovator of Cellular and Molecular Bioengineering."
New research from the Mitchell Lab offers a safer path for CAR T cell immunotherapy
The new method involves attaching a sugar molecule onto the surface of CAR T cells using metabolic labeling, a modification that enables the CAR T cells to attack cancer cells without any hindrance.
Carl June to receive the 2024 Breakthrough Prize in Life Sciences
June was awarded for the development of chimeric antigen receptor (CAR) T cell immunotherapy.